
The genetic bleeding disorder affects more than 2,000 people in the UK

Approximately one in every 50,000 people worldwide are affected by the rare genetic disorder

The genetic bleeding disorder affects an estimated one per every 19,283 male births in the US

The rare genetic condition occurs in approximately one in every 50,000 people in the UK

More than 42,000 people globally are living with the rare bleeding disorder

More than 2,000 people in the UK are currently living with the genetic bleeding disorder

More than 38,000 people worldwide are currently affected by the inherited bleeding disorder

The company has been seeking approval for use of the therapy in adults with severe or moderately severe haemophilia B without a history of factor IX inhibitors

Typically, haemophilia B patients must adhere to strict, lifelong IV infusion schedules

A one-off, intravenous dose of the therapy candidate reduced bleeding by 71%

CSL’s Hemgenix allowed patients to produce mean factor IX activity of 39% at six months

Clinical hold placed following a case of hepatocellular carcinoma in a patient in the trial